Reporting Manager
Steven A. Cohen
Symbol
ANRO
Shares outstanding
31,733,427 shares
Disclosed Ownership
2,824,275 shares
Ownership
8.9%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:30:09 UTC
Date of event
31 Dec 2025
Previous filing
15 May 2025

Sponsored

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 8.9% ownership in Alto Neuroscience, Inc. Common Stock, par value $0.0001 per share (ANRO) on 31 Dec 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Alto Neuroscience, Inc. Common Stock, par value $0.0001 per share (ANRO).
  • Disclosed ownership: 8.9%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 15 May 2025.
  • Current filing was accepted on 17 Feb 2026, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 6.8% 2,156,497 0 2,156,497 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 6.8% 2,156,497 0 2,156,497 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Biotech Private Investments, LLC 2.1% 667,778 0 667,778 /s/ Vincent Tortorella Vincent Tortorella, Authorized Person
Differentiated Ventures Investments, LLC 2.1% 667,778 0 667,778 /s/ Vincent Tortorella Vincent Tortorella, Authorized Person
72 Investment Holdings, LLC 2.1% 667,778 0 667,778 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 8.9% 2,824,275 0 2,824,275 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person